{"nct_id":"NCT03314181","title":"A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2018-04-02","start_date_type":"ACTUAL","primary_completion_date":"2031-05","primary_completion_date_type":"ESTIMATED","completion_date":"2031-05","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}